Costa, AlessiaAi, MinrongNunn, NicolasCulotta, IsabellaHunter, JennaBoudjadja, Mehdi BoutagougaValencia-Torres, LourdesAviello, GabriellaHodson, David J.Snider, Brandy M.Coskun, TamerEmmerson, Paul J.Luckman, Simon M.D'Agostino, Giuseppe2022-03-072022-03-072022-01-01Costa, A, Ai, M, Nunn, N, Culotta, I, Hunter, J, Boudjadja, M B, Valencia-Torres, L, Aviello, G, Hodson, D J, Snider, B M, Coskun, T, Emmerson, P J, Luckman, S M & D'Agostino, G 2022, 'Anorectic and aversive effects of GLP-1 receptor agonism are mediated by brainstem cholecystokinin neurons, and modulated by GIP receptor activation', Molecular Metabolism, vol. 55, pp. 101407. https://doi.org/10.1016/j.molmet.2021.1014072212-8778Bibtex: COSTA2022101407https://hdl.handle.net/2164/18168This work was funded by an MRC Career Development Award (MR/ P009824/1 and MR/P009824/2) to GD’A, as well as an MRC grant to SML/GD’A (MR/T032669/1), a BBSRC grant to SML (BB/M001067/1), and an additional direct contribution from Eli Lilly. D.J.H. was sup- ported by MRC (MR/N00275X/1 and MR/S025618/1), Diabetes UK (17/ 0005681), and the European Research Council (ERC) under the Eu- ropean Union’s Horizon 2020 research and innovation programme (Starting Grant 715884 to D.J.H.). AC was supported for part of this project by a travel grant from the Italian Society of Pharmacology and a fellowship from the Veronesi Foundation (Italy).102456956engBrainAppetiteNauseaGlucagon-like peptide-1Glucose-dependent insulinotropic polypeptideCholecystokininArea postremaNucleus of the solitary tractR MedicineMedical Research Council (MRC)MR/ P009824/1MR/P009824/2MR/T032669/1MR/N00275X/1MR/S025618/1Biotechnology and Biological Sciences Research Council (BBSRC)BB/M001067/1OtherEuropean Commission715884Supplementary DataRAnorectic and aversive effects of GLP-1 receptor agonism are mediated by brainstem cholecystokinin neurons, and modulated by GIP receptor activationJournal article10.1016/j.molmet.2021.101407https://www.sciencedirect.com/science/article/pii/S221287782100265955